Folic acid for prevention of neural tube defects;FOLSAURE ZUR VERHUTUNG VON NEURALROHRDEFEKTEN

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 5, 1996, Pages 177-187

  Tonz O ^a,b   Luthy J ^a   Raunhardt, O ^a  

^a Eidg Ernährungskommission   (United States)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ELEVIT; FOLI RIVO; FOLIC ACID; MATERNA; NEOBRON; NESTROVIT; UNCLASSIFIED DRUG; ANTIANEMIC AGENT;

FOLIC ACID DEFICIENCY; HUMAN; NEURAL TUBE DEFECT; NUTRITIONAL SUPPORT; REVIEW; SPINA BIFIDA; SUBSTITUTION THERAPY; CHEMISTRY; CONGENITAL MALFORMATION; FEMALE; LAW; MATERNAL CARE; NEWBORN; NUTRITIONAL REQUIREMENT; PREGNANCY; RECURRENT DISEASE;

ABNORMALITIES; FEMALE; FOLIC ACID; HEMATINICS; HUMANS; INFANT, NEWBORN; LEGISLATION, FOOD; NEURAL TUBE DEFECTS; NUTRITIONAL REQUIREMENTS; PRECONCEPTION CARE; PREGNANCY; RECURRENCE;

EID: 0030567132     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Smithells RW, Sheppard S, Shorah CJ, Seller MJ, Nevin NC et al.: Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980/I: 399-340.
2. Nevin NC, Johnston WP, Merrett JD: Influence of social class on the risk of recurrence of anencephalus and spina bifida. Dev Med Child Neurol 1981; 23: 155-159.
3. Carstairs V, Cole S: Spina bifida and anencephaly in Scotland. Br Med J 1984; 289: 1182-1184.
4. Czeizel AE: Folic acid in the prevention of neural tube defects. J Pediatr Gastroenterol Nutr 1995; 20: 4-16.
5. Pexieder T: Persönliche Mitteilung auf Grund der Eurocat-Daten.
6. Zackai EH: The risk of neural tube defects to first cousins of affected individuals. In: Crandall BD et al.: Prevention of neural tube defects. New York: Academic Press 1978: 99.
7. Lippmann-Hand A, Fraser FC, Biddle CJ: Indications for prenatal diagnosis inrelatives of patients with neural tube defects. Obstet Gynecol 1978; 51: 72-76.
8. Nance WE: Anencephaly and spina bifida: an etiologic hypothesis. Birth-Defects 1971; 7: 97-102.
9. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R et al.: Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983/I: 1027-1031.
10. MRC vitamin study research group: Prevention of neural tube defects. Lancet 1991; 338: 131-137.
11. Czeizel AE, Dudás I: Prevention of the first occurence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835.
12. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS et al.: Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847-2852.
13. Laurence KM, James N, Miller MH: Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J 1981; 282: 1509-1511.
14. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ: Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990; 10: 149-152.
15. Kirke PN, Daly LE, Elwood JH: A randomised trial of low dose folic acid to prevent neural tube defects. Arch Dis Childh 1992; 67: 1442-1446.
16. Mulinaire J, Cordero JF, Erickson JD, Berry RJ: Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1899; 260: 3141-3145.
17. Mills JL, Rhoads GG, Simpson JL, Cunningham GC, Conley MR et al.: The absence of a relation between the periconceptional use of vitamins and neural tube defects. N Engl J Med 1989; 321: 430-435.
18. Werler MW, Shapiro S, Mitchell AA: Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993; 269: 1257-1261.
19. Tolarova M: Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 1982/II: 217.
20. Shaw GNM, Lammer EJ, Wassermann CR, O'Malley CD, Tolarova MM: Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995; 346: 393-396.
21. Wald N: Folic acid in the prevention of neural tube defects. Ann NY Acad Sci 1993; 678: 112-129.
22. Davis BA, Bailey LB, Gregory JF, Toth JP, Dean J, Stevenson RE: Folic acid absorption in women with a history of pregnancy with neural tube defect. Am J Clin Nutr 1995; 62: 782-784.
23. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG: Homocysteine metabolisme in pregnancies complicated by neural tube defects. Lancet 1995; 345: 149-151.
24. 12 are independent risk factors for neural tube defects. Quart J Med 1993; 86: 703-708.
25. van der Put NMJ, Stegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB et al.: Mutated methylenetetrahydrofolate reductase as a risk for spina bifida. Lancet 1995; 346: 1070-1071.
26. Müller H: Neubestimmung und Bewertung der Folsäuregehalte von ausgewählten Lebensmitteln pflanzlicher und tierischer Herkunft. Ern Umsch 1995; 42: 170-174.
27. Bower C, Stanlexy FJ: Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989; 150: 613-618.
28. Coelho CND, Weber JA, Klein NW, Daniels WG, Hoagland TA: Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 1989; 119: 1716-1725.
29. Recommended Dietary Allowances. National Research Council. Washington: National Academy Press 1989.
30. Dtsch Ges Ern: Empfehlungen für die Nährstoffzufuhr. Frankfurt: Umschau-Verlag, 1991.
31. O'Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA et al.: Controlled dietary folate affects folate status in non-pregnant women. J Nutr 1995; 125: 2717-2725.
32. Rufer-Meineke R: Versorgung mit Vitaminen. In: Dritter Schweiz. Ernährungsbericht. Bern: BAG, 1991: 55-69.
33. Heseker H, Adolf T, Eberhardt W, Hartmann S, Herwig A et al.: Lebensmittel- und Nährstoffaufnahme Erwachsener in der Bundesrepublik Deutschland. VERA-Schriftenreihe 1993; (Bd. III): 44.
34. Müller E, Brubacher G, Dirren H, Helminger A, Schär M, Stähelin HB: Ernährung der Einwohner ländlicher Gebiete. Eine Erhebung in der Schweiz. Verlag Hans Huber, Bern, Stuttgart, Toronto 1987.
35. Czeizel AE, Métneki J, Dudás I: Higher rate of multiple births after periconceptional multivitamin supplementation. N Engl J Med 1994; 330: 1689-1690.
36. Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT: Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993; 329: 536-541.
37. Foreman NK, Pearson AD: Maternal diet and primitive neuroectodermal brain tumors in young children [Letter]. N Engl J Med 1993; 329: 1963.
38. Jacob RA, Mei-Miau W, Henning SM, Swendseid ME: Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr 1994; 124: 1072-1080.
39. McCully KS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Path 1969; 56: 111-128.
40. Clarke RJ, Daly L, Robinson K, Naughten E, Cahalane S et al.: Hyperhomocysteinemia: an independent risk for vascular disease. N Engl J Med 1991; 324: 1149-1155.
41. Lashner BA, Heidenreich PA, Su GL, Kane SA, Hanauer SB: Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: a case-control sudy. Gastroenterology 1989; 97: 255-259.
42. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D et al.: Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85: 875-884.
43. Butterworth CE, Hatch KD, Macaluso M, Cole P, Sauberlich HE et al.: Folate deficiency and cervical dysplasias. JAMA 1992; 267: 528-533.
44. Bailey LB: Folate intake recommendations from a nutritional science perspective. Cereal Foods World 1995; 40: 63-66.
45. Wald NJ, Bower C: Folic acid, pernicious anemia and prevention of neural tube defects. Lancet 1994; 343: 307.
46. Biale Y, Lewenthal H: Effects of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Repr Biol 1984; 18: 211-216.
47. Concensus Guidelines: preconception counseling, management and care of the pregnant women with epilepsy. Neurology 1992; 42 (Suppl. 5): 149-160.
48. Chien LT, Krumdieck CL, Scott CW, Butterworth CI: Harmful effects of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics. AM J Clin Nutr 1975; 28: 51-58.
49. Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F: Anticonvulsants, folate levels and pregnancy outcome: a prospective study. Ann Neurol 1987; 27: 176-182.
50. Dept of Health and Human Services. Public Healt Service: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Weekly Rep 1992; 41: RR-14.
51. Netherlandfs Food and Nutrition Council: Report on the relationship bertween folic acid intake and neural tube defects. The Hague, 1992.
52. Koletzko B, von Kries R: Prävention von Neuralrohrdefekten durch Folsäurezufuhr in der Frühschwangerschaft. Der Frauenarzt 1994; 35: 1007-1010.
53. Scott JM, Kirke P, O'Broin S, Weir DG: Folic acid to prevent neural tube defects [Letter]. Lancet 1991; 338: 505.
54. Ranhotra G, Ranum P: Adding folic acid to cereal grain products. Res Dept Techn Bull 1994; 16: 1-8.
55. Beresford SAA: How do we get enough folic acid to prevent some neural tube defects? Am J Publ Health 1994; 84: 348-349.
56. Yetley EA, Rader JI: Folate fortification of cereal-grain products: FDA policies and actions. Cereal Food World 1995; 40: 67-72.
57. Sheppard S, Kevin NC, Seller MJ, Wild J, Smithells RW et al.: Neural tube defects recurrence after "partial" vitamin supplementation. J Med Gen 1989; 26: 326-329.
58. Sutcliff M, Shorah CJ, Perry A, Wild J: Prevention of neural tube defects. Lancet 1993; 342: 1174.
59. Wald NJ, Bower C: Folic acid and the prevention of neural tube defects. Br Med J 1995; 310: 1019-1020.
60. Tönz O: Vitamine und Schwangerschaft. Vitamin-A-Überdosierung bei Genuss von Leber - Verhütung von Neuralrohrdefekten durch Folsäure. Schweiz Ärzteztg 1992; 73: 1472-1475.